Pathogenesis of Breakthrough Infections with SARS-CoV-2 Variants in Syrian Hamsters
J. Plunkard, K. Mulka, R. Zhou, P. Tarwater, W. Zhong, M. Lowman, A. Wong, A. Pekosz, J. Villano
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19, has evolved into multiple variants. Animal models are important to understand variant pathogenesis, particularly for those with mutations that have significant phenotypic or epidemiological effects. Here, cohorts of naive or previously infected Syrian hamsters (Mesocricetus auratus) were infected with variants to investigate viral pathogenesis and disease protection. Naive hamsters infected with SARS-CoV-2 variants had consistent clinical outcomes, tissue viral titers, and pathology, while hamsters that recovered from initial infection and were reinfected demonstrated less severe clinical disease and lung pathology than their naive counterparts. Males had more frequent clinical signs than females in most variant groups, but few sex variations in tissue viral titers and lung pathology were observed. These findings support the use of Syrian hamsters as a SARS-CoV-2 model and highlight the importance of considering sex differences when using this species. ImportanceWith the continued circulation and emergence of new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants, understanding differences between the initial and a subsequent reinfection on disease pathogenesis is critical and highly relevant. This study characterizes Syrian hamsters as an animal model to study reinfection with SARS-CoV-2. Previous infection reduced the disease severity of reinfection with different SARS-CoV-2 variants.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Host response of Syrian hamster to SARS-CoV-2 infection, including differences with humans and between sexes
M. Castellan, G. Zamperin, … S. Leopardi·bioRxiv·Nov 22, 2022
- Impact of reinfection with SARS-CoV-2 Omicron variants in previously infected hamsters
N. Shiwa-Sudo, Y. Sakai, … N. Nagata·bioRxiv·Aug 30, 2022
- Protective immunity of the primary SARS-CoV-2 infection reduces disease severity post re-infection with Delta variants in Syrian hamsters
Sreelekshmy Mohandas, Pragya Dhruv Yadav, … Chandrashekhar Mote·VirusesPeer-reviewed·Mar 13, 2022
- Comparative infectivity and pathogenesis of emerging SARS-CoV-2 variants in Syrian hamsters
R. Abdelnabi, R. Boudewijns, … K. Dallmeier·bioRxiv·Feb 26, 2021
- Pathogenic and transcriptomic differences of emerging SARS-CoV-2 variants in the Syrian golden hamster model
K. L. O'Donnell, A. N. Pinski, … A. Marzi·bioRxiv·Jul 11, 2021
- SARS-CoV-2 B.1.1.7 infection of Syrian hamster does not cause more severe disease and is protected by naturally acquired immunity
I. A. Nunez, C. Z. Lien, … T. Wang·bioRxiv·Apr 2, 2021